Daweynta Antibodies Marka Cus waa caadi
Daaweynta qanjidhka ka hortagga ah waa mawduuc murugo leh. Ma jiraan wax aad sameyn kartid si aad uga hortagto xaalad tayroodh ah, ama inaad ka sii darto sii xumeynta? Haddii aad waydiiso, qaar ka mid ah dhakhtarka indhaha ayaa kaa joojin doona, ama kuu sheegi doona inaanad lahayn xulasho daaweyn. Natiijooyinka baadhitaanka, si kastaba ha ahaatee, waxay taageertaa fahamka Hashimoto's thyroiditis - cudur isdaba joog ah oo sababa hypotyroidism, xaqiiq ahaan, laga yaabo in laga hortago, loona yareeyo, ama xitaa la joojiyo intaan la gaarin ka hor intaanay horay u sii wadi doonin qanjidhada hungurigaaga iyo hypothyroidism.
Shirkada Endocrine Society Endo 2005 shirkii Dr. Ending, Dr. Ting Chang iyo asxaabtiisuba waxay soo wariyeen in la siinayo daawada loo yaqaan 'thyroid hormone drug levothyroxine' (magaca caanka ah ee loo yaqaan 'Synthroid, Levoxyl, iyo Tirosint') oo loogu talagalay dadka qaba cudurka thyroiditis ee Hashimoto. Bukaanadaas waxay qabeen qiyaas caadi ah oo ah qanjirka 'thyroid stimulating hormone' (TSH ), waxaana loo qoondeeyey "Euthyroid", taas oo micnaheedu yahay in heerkooda GB ay ahaayeen kuwa caadiga ah. Tilmaame ka mid ah hidde-wade Hashimoto's thyroiditis.
Kala badh bukaanka ayaa la siiyay levothyroxin muddo lix bilood ah badhkii kalena ma aysan helin daaweyn daroogo. Tijaabooyinka shaqeynta tayroodhka iyo tiknoolajiyeyaasha autoantibody ayaa la qiyaasay ka hor iyo ka dib 6 bilood gudahood. Natiijooyinka waxay ahaayeen muhiim:
- Kuwa helaya levothyroxine waxay si aad ah hoos ugu dhigeen heerarka "autoantibody" , heerarka antibodyka ayaa dhab ahaantii kordhay qaar ka mid ah kooxda aan la daaweyn.
- Qiimaha TSH ayaa hoos u dhacay kooxda la daweeyay, celcelis ahaan 0.5 iyo 2.5 ee kooxda aan la daaweyn.
Cilmi baarayaashu waxay soo gabagabeeyeen in daaweynta prophylactic (prophylactic) hore loo daaweyn karo faa'iido ay ku yeelan karto hoos u dhigida horumarka ka yimaada otomaatiga Hashimoto ee thyroiditis.
Tani maahan daraasadda ugu horreysa ee lagu muujinayo in daaweynta ka hortagga ah ay kor u qaadi karto horumarka Hashimoto ama horumarinta hypothyroidism.
Bishii Maarso 2001 ee daabacaadda The Thyroid , cilmi-baarayaasha Jarmalka ayaa ka warramay daraasaddooda baaritaanka bukaannada qaba cudurka Ettyroid Hashimoto, kala badh ka mid ah ayaa lagu daaweeyay levothyroxin muddo sannad ah, badhkii kalena aan la daaweyn. Ka dib 1 sano, heerarka difaaca jirka iyo lymphocytes, kuwaas oo ah caddaynta barar, waxay si weyn hoos ugu dhacday kooxda oo heleysa daawada. Kooxo aan la daaweynin, heerarka antiboodku way kaceen ama way isku mid ahaayeen.
Cilmi-baadhayaasha ayaa soo gabagabeeyay in daaweynta ka hortagga ah ee dadka bukaanka ah ee Hashimoto ay hoos u dhigtay calaamadaha kala duwan ee tirakoobka . Waxay kaloo sheegeen in daaweynta noocaas ahi ay joojin karto horumarka cudurka Hashimoto, ama laga yaabo inay ka hortagto horumarinta hypothyroidism.
Daraasad kale, cilmi-baarayaasha Japan waxay ogaadeen in daaweynta levothyroxine ay yareyn karto jiritaanka Hashimoto's thyroiditis, iyo sidoo kale in la yareeyo astaamaha cudurka.
Daraasada bukaanka qaba cudurka Ettyroid Hashimoto, koox ka mid ah bukaannada ayaa la siiyay daaweynta levothyroxin, kooxda kalena ma helin daaweyn. Ka dib 15 bilood ka dib, kooxda daaweyntu waxay si aad ah u kordhisey heerarka T4 oo aad u sarreeya, hoos u dhaca hoos-u-dhigga TSH, iyo hoos u dhigidda antibiyootiga anti-thyroglobulin (Tg-Ab) iyo heerarka antibiyootiga ee anti-thyroid peroxidase.
Cabbirka qanjidhada qanjidhka ayaa sidoo kale hoos u dhacay kooxda la daweeyey, halka kuwa aan helin daaweyntu ay korodheen cabbirka qanjirada , calaamadeeynta caabuqa qanjirka.
Cilmi-baadhayaasha ayaa sheegay in inkastoo daweynta levothyroxin ay tahay "khasab in bukaan-socodka thyroiditis hypothyroid autoimmune thyroiditis , daaweynta taas oo lagu muujiyay in ay joojiso hannaanka gawaarida ee maadooyinka xayawaanka ayaa weli muran ka qaba bukaanka cudurka Hashimoto ee cudur-sidaha oo aan cudurku ku dhicin qanjirka thyroid ku filan inuu keeno hypothyroidism. "
Waxay ku heleen, si kastaba ha ahaatee, daaweynta levothyroxin ee qiyaasaha qaadista heerarka hooseeya waxay u muuqataa mid waxtar leh maaha oo kaliya hoos u dhigida heerka qalabka tooska ah laakiin sidoo kale xajmiga goiter, taas oo ugu dambeyntii ka hortagi karta horumarka hypotheryroidism.
Ereyga ka
Sida aad arki karto, waxaa jira baaritaan muhiim ah oo muujinaya in daaweynta ka hortagga ah ee levothyroxin laga yaabo in lagu damaanad qaado dadka qaba cudurka Ettyroid Hashimoto, oo leh heerarka caadiga ah ee TSHka laakiin heerarka antibiyu muujinayaan caddaynta cudurkeenaha Hashimoto . Daaweyntan noocan oo kale ah waxay kicisaa calaamadaha cudurka hypothyroidism, waxay hoos u dhigtaa sare u qaadidda difaaca jirka ee korontada , waxay ka caawisaa ka hortagga in ay ka sii darayso cudurkeenaha autoimmune , iyo ka hortagga horumarka hypothyroidism.
Haddii aad leedahay calaamadaha thyroid , heerka "caadiga ah" TSH , laakiin aan lagaa baarin difaaca jirka, waxaad ku adkaysataa in lagugu sameeyo baaritaanka TPO ee uu sameeyo dhaqtarkaaga.
Haddii aad leedahay calaamadaha thyroid, heerka "caadiga ah" TSH, iyo kor u qaadista difaaca jirka, waxaad tixgelisaa inaad waydiisatid daaweyn, iyo haddii dhakhtarkaagu aanu rabin, tixgelin si aad u hesho dhakhtar aqoon u leh ama furan .
Ilaha
En-Ting Chang, Du-An Wu, Dee Pei, Shi-Wen Kuo, Ming-Chen Hsieh. [P2-552] Saameyntii Maamulka L-Thyroxine ee bukaanada qaba Eyryroid Hashimoto's Thyroiditis. Endocrine Society Endo 2005 Abstracts
"Tirada, 2001 Maarso; 11 (3): 249-55," Daaweynta qiyaasaha ee halista ah ee daaweynta unugyada Hashimoto ee bukaansocotitis ee leh levothyroxine: ma jirtaa wax faa'iido leh? "
Duygu Yazgan Aksoy, et. al. "Saamaynta Hurgumada Qanjidhka Qanjirka 'Thyroid Hyrone Prothyroid' ee Eyryroid Hashimoto 'Thyroiditis'" Endocr J (Japan) Vol. 52: 337-343, (2005).